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It is my great pleasure to introduce the current issue of “Nu-
clear Medicine Review”. This time, the chapter “Original articles” 
opens the paper written by Hungarian colleagues from Budapest 
“In vitro and biodistribution examinations of Tc-99m labelled 
doxorubicin-loaded nanoparticles”. The authors concluded that 
different and stable particle sizes make drug carrier human serum 
albumine nanoparticles possible to apply different drug targeting 
in a potential clinical use.
The second interesting paper about the V/Q scanning in 
young women from Prague/Czech Republic showed that 42% 
patients on hormonal contraception  had scintigraphic signs of 
pulmonary embolism and 19% of them had clinical signs of deep 
venous system thrombosis of the lower limbs. It seems that the 
risk of venous thromboembolism related to the use of hormonal 
contraception needs to be considered as a cause of pulmonary 
embolism even among very young females. 
From the next article from Poznan /Poland we learned that focal 
increased 18F-FDG uptake was found in 3.7 %of patients and the 
probability of malignancy of these lesions  is rather high. 
“Can treatment with radiolabeled somatostatin analogue 
increase the survival rate in patients with nonfunctioning neu-
roendocrine pancreatic tumors?” is the title of the next polish 
original paper from Krakow.  The authors concluded that peptide 
receptor radionuclide therapy is safe and effective treatment 
option in patients with this neoplasm  and there is no statisti-
cally significant difference in survival rate in in comparison to 
patients with neuroendocrine tumoursof the other localization 
treated in the same way.
The colleagues form Cluj-Napoca/Romania assessed the 
possibility to perform 99mTc -Tetrofosmine for dynamic hepatobiliary 
scintigraphy to obtain the good quality of scintigraphic images. 
That allowed  the correct diagnosis of biliary dyskinesia, stasis, 
stenosis and fistulas. The necessary dose is approximately 8 to 20 
times smaller than that used for myocardial perfusion scintigraphy. 
And the sixth original paper from Otwock/Poland compared 
the receptor affinity of natSc-DOTA-TATE  versus natGa-DOTA-TATE. 
44Sc as positron emitter can be an interesting alternative to 68Ga 
due to its longer half life. Moreover the - emitter 47Sc can be used 
for therapy using the same biomolecule vectors in the future. 
They proved that binding affinity of natGa-DOTA-TATE appeared 
higher than that of natSc-DOTA-TATE. Further in vitro and in vivo 
studies are needed  in order to verify the influence of the chelated 
metal on the affinity and uptake of the respective radiolabeled 
compounds.
 Dear Sirs and Madams,
The Review part of current Nuclear Medicine Review consist 
of three very interesting papers. The first review on the compari-
son of [64Cu]-ATSM PET in molecular imaging of tumor hypoxia 
with the classical [18F]-MISO written by French colleagues from 
Nantes elucidates that64Cu-ATSM appears superior in terms of 
imaging performances calling for an industrial and clinical devel-
opment of this innovative radiopharmaceutical. The next article 
“Radioisotope therapy of cancer bone metastases” by Maciej 
Bączyk from Poznan/Poland concluded that radioisotopes are 
an important addition to the armamentarium of clinicians who 
take care of patients with advanced cancer and painful cancer 
bone metastases .
The paper “Bone metastases diagnosing possibilities in 
studies with the use of 18F-NaF and 18F-FDG” from Kielce and 
Warsaw/Poland  is comparing the role of 18F-NaF and 18F-FDG in 
diagnosis of bone metastases. 
In this issue of Nuclear Medicine Review there are four inter-
esting clinical cases.
The authors from Toulouse/France described the false-positive 
finding in therapeutic evaluation in a lymphoma patient follow-
ing FDG extravasation. The role of gated myocardial perfusion 
scintigraphy (GMPS) in myocarditis was discussed by Iranian 
scientists from Bushehr is the next interesting  report. Polish physi-
cians from Warsaw/Poland visualized persistence of splenic tissue 
after splenectomy in 80-yr-old man with idiopathic thrombocyto-
penic purpura. And Italian authors from Rozzano (MI) reported the 
case of 11C-choline PET/CT in locally advanced prostate cancer. 
11C-choline has a negligible urinary elimination which, in selected 
cases, ends up to be an advantage. 
The chapter Past Events includes a short relation from the 
opening ceremony of the new PET-CT-NMR center in Krakow/Po-
land and a Report from the 1st World Congress on Gallium-68 and 
Peptide Receptor Radio Nuclide Therapy (PRRNT).
In the end of my letter I would like to wish all of you Merry 
Christmas, I hope that this issue of Nuclear Medicine Review will 
be found under your Christmas Tree. And Happy New Year!
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